DNA methylation changes in hematologic malignancies: biologic and clinical implications.

JPJ Issa, SB Baylin, JG Herman - Leukemia (08876924), 1997 - search.ebscohost.com
DNA methylation changes are among the most common detectable abnormalities in human
neoplasia. Hypermethylation within the promoters of selected genes appears to be …

DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia

B Rüter, PW Wijermans, M Lübbert - International journal of hematology, 2004 - Springer
DNA methylation provides a major epigenetic code (besides histone modification) of the
lineage-and developmentspecific genes (such as regulators of differentiation in the …

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS

G Leone, MT Voso, L Teofili, M Lübbert - Clinical Immunology, 2003 - Elsevier
DNA methylation abnormalities have recently emerged as one of the most frequent
molecular changes in hematopoietic neoplasms. Since methylation and transcriptional …

Role of epigenetic changes in hematological malignancies

U Lehmann, K Brakensiek, H Kreipe - Annals of hematology, 2004 - Springer
Inactivation of tumor suppressor genes is an important event contributing to the development
of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point …

DNA methylation as a therapeutic target in cancer

JPJ Issa - Clinical Cancer Research, 2007 - AACR
Targeting DNA methylation for cancer therapy has had a rocky history. The first reports on
DNA methylation changes in cancer described global loss of methylation, which has been …

Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications

V Santini, HM Kantarjian, JP Issa - Annals of internal medicine, 2001 - acpjournals.org
Methylation of DNA is a biochemical modification that can influence gene expression and is
involved in inactivating one of the two X chromosomes in women. Evidence that has …

The DNA methylation landscape of hematological malignancies: an update

P Blecua, L Martinez‐Verbo, M Esteller - Molecular Oncology, 2020 - Wiley Online Library
The rapid advances in high‐throughput sequencing technologies have made it more evident
that epigenetic modifications orchestrate a plethora of complex biological processes. During …

DNA methylation profiles of lymphoid and hematopoietic malignancies

T Takahashi, N Shivapurkar, J Reddy… - Clinical cancer …, 2004 - AACR
Purpose: Aberrant methylation of the 5′ gene promoter regions is an epigenetic
phenomenon that is the major mechanism for silencing of tumor suppressor genes in many …

DNA methylation and cancer therapy: new developments and expectations

M Esteller - Current opinion in oncology, 2005 - journals.lww.com
We are at the dawn of an era when epigenetic drugs will be an important weapon in our
arsenal in the war against cancer. Hematological malignancies have provided a promising …

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

O Galm, S Wilop, C Lüders, E Jost, G Gehbauer… - Annals of …, 2005 - Springer
Hypermethylation of CpG islands near gene promoter regions is associated with
transcriptional inactivation and represents an important mechanism of gene silencing in …